Overview
Periodontitis can manifest as a complication of systemic diseases, particularly those involving hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin, leading to conditions such as aspirin-exacerbated respiratory disease (AERD). 1234Diagnosis
Anamnestic History: Essential for identifying sensitivity to aspirin and other NSAIDs, often presenting with urticaria, angioedema, or respiratory symptoms. 2
Challenge Tests: Oral challenge with acetylsalicylic acid (ASA) can confirm sensitivity; positive in approximately 92.4% of cases. 2
Histamine Levels: Elevated resting plasma histamine levels in patients with aspirin-induced reactions, which decrease during adverse reactions. 3
Cross-Reactivity: Patients sensitive to aspirin often react similarly to other NSAIDs like indomethacin. 2Management
Avoidance of Triggering Agents: Strict avoidance of NSAIDs and specific triggering agents like indomethacin, ibuprofen, and others listed in 4.
Aspirin Desensitization: Effective therapy for AERD, allowing subsequent aspirin use for cardiovascular protection; cost-effective compared to alternatives like clopidogrel. 1
Alternative Analgesics: Safe alternatives include salicylamide, dextropropoxyphene, benzydamine, and chloroquine for patients with aspirin-induced asthma or urticaria. 4Special Populations
No Specific Guidance Provided: Abstracts do not provide detailed management or diagnostic considerations specific to pregnancy, pediatrics, elderly, or comorbidities related to periodontitis as a manifestation of systemic disease. 1234Key Recommendations
Perform oral acetylsalicylic acid challenge tests to confirm aspirin sensitivity in patients with suspected urticaria/angioedema or respiratory symptoms exacerbated by NSAIDs. (Evidence: Moderate) 2
Implement aspirin desensitization as a therapeutic approach for patients with aspirin-exacerbated respiratory disease to enable aspirin use for cardiovascular protection, noting its cost-effectiveness. (Evidence: Strong) 1
Avoid NSAIDs and specific triggering agents in patients with documented sensitivity; consider alternative analgesics like salicylamide or chloroquine for pain management. (Evidence: Expert opinion) 4References
1 Shaker M, Lobb A, Jenkins P, O'Rourke D, Takemoto SK, Sheth S et al.. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease. The Journal of allergy and clinical immunology 2008. link
2 Grzelewska-Rzymowska I, Szmidt M, Rozniecki J. Urticaria/angioedema-type sensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Diagnostic value of anamnesis and challenge test with acetylsalicylic acid. Journal of investigational allergology & clinical immunology 1992. link
3 Asad SI, Murdoch R, Youlten LJ, Lessof MH. Plasma level of histamine in aspirin-sensitive urticaria. Annals of allergy 1987. link
4 Szczeklik A. Antipyretic analgesics and the allergic patient. The American journal of medicine 1983. link90236-x)